register

Digital & Innovation

National AI plan criticised as ‘turning up to a global race in thongs’

Health Industry Hub | December 3, 2025 |

The government has released its long-awaited National AI Plan, but experts warn it is full of promises but lacking the investment, regulation, and urgency Australia desperately needs to compete in the global AI race.

Dr Sue Keay, Director of UNSW’s AI Institute, said “Australia has finally released a National AI Plan, and while it’s nice to see all the right ingredients listed, once again, we’re stuck with a recipe that forgets the actual cooking. The plan rightly lists everything we should be doing, but fails to commit to any real investment or any sense of urgency.

“It’s hard not to feel like we’re turning up to a global race in thongs, asking where the starting line is, while everyone else is already sprinting to the finish line. If we’re serious about building a world-class AI ecosystem, we need more than the right words in a digital document. We need ambition, investment, and a sense of pace that matches reality.”

Professor Toby Walsh, an AI expert from UNSW School of Computer Science and Engineering, said “The long awaited National AI Plan says all the right things but lacks ambition and commitment. It’s hard not to compare against the UK’s AI growth plan announced one week ago with AU$48 billion of investment, both public and private, into the AI sector in the UK promised in the last month alone. The Australian plan includes just $30 million for a much needed AI Safety Institute.”

The National AI Plan highlights the economic opportunities of AI, but based on what we know so far, it leaves important gaps in how Australia manages the risks. Relying on existing laws sounds practical, but those laws were not designed for powerful modern AI systems. 

“Opening up more public and private data could help businesses innovate, but it must be done safely. We need clear rules about how data can be shared, strong privacy protections, and consistent standards for the development and testing of AI systems – especially in sensitive areas like health…,” said Associate Professor Niusha Shafiabady, Department of Information Technology, Peter Faber Business School at Australian Catholic University.

Key stakeholders have weighed in on the government’s AI healthcare report, assessing whether it hit the mark, highlighted critical gaps, and set out expectations for the government’s next steps.

Yet, Professor Walsh criticised the government for backtracking on regulation, despite former Minister for Industry and Science Ed Husic’s earlier support.

“There will be fresh harms that AI introduces, outside of existing regulation. If it is good enough for Europe, why is new AI regulation not needed here?” he questioned.

Reports from the Australian Academy of Technological Sciences and Engineering (ATSE) and the Australian Council of Learned Academies (ACOLA) have repeatedly called for stronger investment and regulation. Yet, six years later, the government still seems content to drift along.

“We will miss this boat if we don’t steer a better course,” Professor Walsh warned. “Where else does the government expect the desperately needed productivity gains to come from if not from technologies like AI?”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.